123 filings
Page 5 of 7
S-8
w0j rx1e14ft93
23 Mar 21
Registration of securities for employees
4:50pm
10-K
ty16 fq30yq65q
23 Mar 21
Annual report
4:21pm
8-K
wfp2alf7
23 Mar 21
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020
4:10pm
8-K
g9383zl8z09ri2djb4i
11 Jan 21
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
6:36am
424B4
08v1h 8sc5vhgy
13 Nov 20
Prospectus supplement with pricing info
5:21pm
S-1MEF
cape5g
13 Nov 20
Registration of additional securities for an S-1
6:05am
EFFECT
enwun
13 Nov 20
Notice of effectiveness
12:15am
CORRESP
duf4d
10 Nov 20
Correspondence with SEC
12:00am
CORRESP
mjony9z udyo8
10 Nov 20
Correspondence with SEC
12:00am
8-K
lc2ki8l04g3nl1y8
5 Nov 20
ORIC Pharmaceuticals Reports Third Quarter 2020
4:18pm
8-K
gned 5rpdi4
19 Oct 20
Other Events
4:09pm
8-K
55uqljx st4hl36sgy
5 Aug 20
ORIC Pharmaceuticals Reports Second Quarter 2020
4:15pm
UPLOAD
24jlk
28 Jul 20
Letter from SEC
12:00am
DRS
tdku459h72gh1
20 Jul 20
Draft registration statement
12:00am
8-K
40od 5zlzcl75k45r
10 Jun 20
ORIC Pharmaceuticals Appoints Lori Kunkel, M.D., to its Board of Directors
6:02am
10-Q
omeue2o86eaqv8ug
20 May 20
Quarterly report
4:31pm
8-K
em6f24zynouvs62 vz
20 May 20
ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results
4:25pm